These results suggest that FEN1 was highly expressed in HCC and might serve as a potential biomarker for prognosis and diagnosis of HCC patients besides being a therapeutic target for improving HCC prognosis. This evidence concerns the gene FEN1 and hepatocellular carcinoma.